“showed a trend”

Both S group and P group showed a trend for increased NR1 expression (AVOVA, p = 0.17).

There was no significant difference in the amount of chronic stress between the two groups of subjects in the preceding month, but patients with fibromyalgia showed a trend towards a greater exposure to chronic stress (20.00 versus 14.38, p = .17, see table 1 ).

While not reaching statistical significance, we did observe that in the ROR-low group of ERpHER2nLNn adjuvant endocrine-treated group of patients >50 years at diagnosis, patients with LumA NC – Normal NC_2nd tumors showed a trend toward better overall survival (log-rank p = 0.17, Fig. 2e ).

After irAEs were resolved, ICI resumption showed a trend towards improved PFS (12.1 vs. 7.9 months, p=0.17) and OS (27.5 vs. 18.0 months, p=0.73) ( Fig. 3 ). 7.

Among the other available variables, V37 Gy (cc) was of borderline significance while MLD > 5.5 Gy, hypertension and smoking showed a trend ( p -value = 0.17 and 0.20 respectively) with ORs around 2.

Based on a systematic review and meta-analysis of randomized controlled trials, compared with standard therapy, the addition of SF showed a trend of decreasing 28-day mortality ( p = 0.17) only for the septic shock patients, with 4.5 mmol/L ≤ mean arterial lactate level < 7 mmol/L and with a yang-qi deficiency (a TCM syndrome) [ 72 ].

We did not find significant tumor PAI at these loci, though CDKN2A and IKZF1 SNPs showed a trend towards preferential selection of the risk allele (p = 0.17 and p = 0.23, respectively).

In old patient and young patient populations, there was no significant association of different BRAF mutations with gender, although male patients showed a trend of higher incidence of p.V600K, class-2 or class-3 mutations ( P = 0.17) and a lower incidence of p.V600E mutation ( P = 0.07) in the old patient population.

While correlation with BM infiltration in paired plasma samples showed a trend toward positive correlation ( Figure 3B , Spearman 0.39 (95%CI −0.2 to 0.77), P=0.171), this comparison did not reach significance, most likely due to two outlier patients (Pt01V, Pt02V) with high tumor burden measured in cfDNA but low BM infiltration ( Figure 3C ).

The fast‐track program showed a trend of decreased risk of short‐term SWL (OR 0.40; P = 0.171), but this decrease was not statistically significant.

PCA in isolation also showed a trend toward a reduction in IL‐1β secretion (16.8 ± 15.0%, p = 0.171).

Nonetheless, although the data we obtained in our series showed a trend (p = 0.172) in this subgroup of patients, we still lack randomized studies to support this assumption.

OS2 showed a trend of benefit in group A without statistical significance (10.5 months versus 6.5 months, P =0.172), while median OS was 22 months in group A compared with 16 months in group B, P =0.048 (Figure 2 ).

Comparison of prognosis in patients without FLT3 ITD mutation stratified by NPM1 genotype status at diagnosis and relapse Patients with NPM1 mutation at diagnosis showed a trend towards a better outcome, such as longer OS (24.6 vs. 17.3 months; P =0.173) and duration of CR (10.0 vs. 7.5 months; P =0.558) than those without NPM1 mutation at diagnosis.

An operation time > 255 minutes showed a trend (12.2% vs 5.5%, OR 2.38; P = .173) but did not reach significance. 3.6.

However, Saudi nationality showed a trend (p=0.174), with an odds ratio of 2.113 (95% CI: 0.718-6.219).

Upon discharge, the RA-MIS group showed a trend toward better functional outcomes, with a mean mRS score of 3.29 ± 1.628 compared to 3.90 ± 1.210 in the craniotomy group ( P = 0.174, Figure 4F ).

Although both OS and RFS showed a trend favoring the laparoscopic group, these differences did not reach statistical significance (OS: P = 0.174; HR, 0.78; 95% CI, 0.55–1.11; RFS: P = 0.166; HR, 0.78; 95% CI, 0.56–1.11). 65.3% of patients in the LG group and 71.1% of patients in the OG group experienced recurrence ( P = 0.472) (Table 3 and Supplementary Table S5).

Although CUMS rats showed a trend toward an increased duration ratio of the peripheral to the central area than controls (P = 0.175), there were no significant differences between the four groups (F[3, 41] = 0.680, P = 0.569; Supplementary Figure S1C ).

The advanced-stage disease showed a trend toward higher relapse risk (OR = 2.19, 95% CI 0.71–6.78, p = 0.175), consistent with the higher relapse rate observed (44.8% vs. 28.0%).

Notably, donepezil-treated aged mice showed a trend toward smaller MAA compared to aged untreated animals, approaching statistical significance ( p = 0.1756).

No significant between-group differences were observed in the sleep parameters recorded in the sleep diary at any of the study visits ( Table 2 ), but the FIR-pajamas group showed a trend toward improvement over the sham pajamas group in WASO with a small effect size at week 6 (dppc2 = 0.327, p = 0.176). 3.4.3.

Compound A showed a trend for improvement ( p = 0.176).

3.3 Prognosis With a median follow-up time of 31.2 months (range: 5.5 – 88.6) in the total population, the IC-PCE group showed a trend toward better PFS and OS than the CRT group (2-year PFS: 55.6% vs. 33.3%, log-rank p =0.176, 2-year OS: 92.6% vs. 79.0%, log-rank p =0.541) ( Figures 2A, B ).

In multivariable Cox analysis, admission BT < 36 °C showed a trend at 30 days (Adjusted HR: 1.87; p = 0.176; 22 events) and became a significant independent predictor at 180 days (Adjusted HR: 2.30; p = 0.039; 34 events).